During development of the nervous system, axons and growth cones contain mRNAs such as β-actin, cofilin and RhoA, which are locally translated in response to guidance cues. Intra-axonal translation of these mRNAs results in local morphological responses; however, other functions of intra-axonal mRNA translation remain unknown. Here, we show that axons of developing mammalian neurons contain mRNA encoding the cAMP-responsive element (CRE)-binding protein (CREB). CREB is translated within axons in response to nerve growth factor (NGF) and is retrogradely trafficked to the cell body. In neurons that are selectively deficient in axonal CREB transcripts, increases in nuclear pCREB, CRE-mediated transcription and neuronal survival elicited by axonal application of NGF are abolished, indicating a signalling function for axonally synthesized CREB. These studies identify a signalling role for axonally derived CREB, and indicate that signal-dependent synthesis and retrograde trafficking of transcription factors enables specific transcriptional responses to signalling events at distal axons.
. This mechanism is particularly evident in the axons of developing neurons, which contain mRNAs, ribosomes and other translational machinery 2 . Most known axonal mRNAs encode proteins that are involved in cytoskeletal regulation and are also involved in mediating the response to guidance cues [3] [4] [5] . Roles for axonal mRNA translation in other processes have not been established.
One critical function of axons during development is to detect signals in the extracellular environment and to transduce these signals into changes in gene expression in the nucleus [6] [7] [8] [9] . In developing sympathetic and sensory axons, growth cones detect NGF synthesised by target cells, resulting in the generation of a retrograde signal that is conveyed to the soma that, in turn, promotes neuronal survival 10 .
Here, we describe a role for axonal mRNA translation in the regulation of neuronal survival and nuclear transcription elicited by axonal application of NGF. NGF triggers axonal protein synthesis, which is required for NGF-mediated retrograde survival. A cDNA library prepared from the axons of developing sensory neurons reveals that CREB mRNA is an axonally localized transcript. CREB is selectively translated in axons in response to NGF and retrogradely trafficked to the cell body. Furthermore, selective knockdown of axonal CREB mRNA reveals that axonally synthesized CREB is required for NGF at axons to promote the accumulation of pCREB in the nucleus, transcription of a CRE-containing reporter gene and neuronal survival. These data identify a role for axonally synthesized CREB, and identify a signalling mechanism involving intra-axonal translation and retrograde trafficking of transcription factors that may have critical roles in signalling from axons to the nucleus.
RESULTS

Retrograde NGF signalling at axon terminals requires protein synthesis
The signalling pathways downstream of NGF in growth cones are unclear. To determine whether NGF regulates local protein synthesis, embryonic day 15 (E15) dorsal root ganglia (DRG) cultures (see Supplementary  Information, Fig. S1a , b) were transferred to NGF-free media for 2 h and then stimulated with NGF or vehicle for 1 h. NGF treatment resulted in increased phosphorylation of the translational regulatory protein 4E-BP1 at Ser 64 and Thr 69 in axons (Fig. 1a, b) . Multi-site phosphorylation of 4E-BP1 is required for mRNA translation 11 , indicating that NGF may induce local protein synthesis.
To determine whether protein synthesis is required for NGF signalling, neurons were cultured in compartmented chambers that permit selective application of NGF to either distal axons or cell bodies 12 , mimicking the physiologically selective exposure of distal axons to NGF that occurs as axons approach NGF-synthesizing target tissues ( Fig. 1c and see Supplementary Information, Fig. S1c-f ). Axonal application of NGF activates a survival pathway that uses CREB and resembles the physiologic requirement for CREB 13 ; bath application seems to use different NGF signalling pathways, as it induces survival in the absence of CREB 13 . Axons crossed the divider by day in vitro (DIV) 5, at which point the media in the cell body compartment was replaced with NGF-free media and the media in the axonal compartment is replaced with either NGFfree or NGF-replete media for an additional 48 h. Application of NGF exclusively to the axonal compartment resulted in a significant increase in neuronal survival compared to vehicle-treated axons (Fig. 1d, e) . This effect required intra-axonal protein synthesis, as axonal application of cycloheximide or anisomycin, together with NGF, resulted in a significant reduction in survival compared to NGF alone (Fig. 1d, e) . The fluidic isolation of treatments was confirmed by the observation that axonal application of translation inhibitors had no effect in the cell body compartment on a membrane-anchored translation reporter (see Supplementary Information, Fig. S1e, f) . Furthermore, incubation of translation inhibitors in the cell body compartment supported DRG survival, even in the absence of NGF (Fig. 1e) , consistent with previous results showing that inhibition of protein synthesis in various cells (including DRG neurons) promotes survival due to the requirement for new protein synthesis in apoptosis [14] [15] [16] .
CREB mRNA is localized to axons
To identify mRNAs that act downstream of NGF in axons, the Boyden chamber technique for isolating axons 17 was modified to obtain distal axons (Fig. 2a ) 4 . DRG explants were cultured on 12-mm coverslips placed in the centre of Boyden chambers. Axons grow across the Dissociated DRG neurons were grown in compartmentalized chambers and vehicle or NGF was added to the axon compartment. Cycloheximide (CHX; 1 µM) or anisomycin (aniso; 40 µM) were added to the axon compartment concurrently with NGF media. Cell body compartments were kept NGFfree during the course of the experiment. Cells crossing the divider were retrogradely labelled with WGA-Alexa555 and only WGA-positive cell bodies were counted in the data set. Survival was assessed by TUNEL assay. coverslip and then grow through the membrane towards the higher NGF concentration in the lower chamber. Axons from six chambers were harvested by scraping the underside of the membrane and used for reverse transcription and cDNA amplification using a protocol designed for unbiased amplification of mRNA from single cells 18 (see Supplementary Information, Methods) . Among the clones in the library, cDNAs encoding specific transcription factors, including CREB, were identified. To confirm that CREB transcripts are localized to axons, fluorescent in situ hybridisation (FISH) experiments using E15 DRG explant cultures were performed. CREB-specific riboprobes prominently labelled cell bodies (Fig. 2b) , with lower levels detectable in axons (Fig. 2b, c) . Probes directed against other transcription factor transcripts, such as c-Jun and STAT1, resulted in negligible labelling of axons (Fig. 2b, c) . CREB FISH signals were markedly reduced in neurons transfected with CREB-specific small interference RNA (siRNA; Fig. 2d,e) , as well as in DRG neurons cultured from mice homozygous for a hypomorphic CREB allele 19 (see Supplementary Information, Fig. S1g,  h ). RT-PCR using two distinct primer pairs resulted in amplification of CREB transcripts from distal axon preparations from Boyden chambers 4 , as well as amplification of β-actin, a previously-identified axonal mRNA 20 , whereas RT-PCR signals for other transcription factor transcripts were absent (Fig. 2f) . The axonal localization of CREB mRNA is reminiscent of a previous report localizing CREB mRNA and protein to dendrites 21 . Taken together, these data indicate that CREB transcripts are specifically localized to axons in developing DRG neurons.
CREB is synthesized in axon terminals in response to NGF
The presence of axonal CREB mRNA raises the possibility of intra-axonal CREB synthesis. To address this hypothesis, DRG explants were cultured in Boyden chambers, the media in the cell body chamber was replaced with NGF-free media, and the media in the axon chamber was replaced with either NGF-replete or NGF-free media for 3 h. Extracts from the upper surface of the Boyden chamber (containing cell bodies and proximal axons) and the lower surface (containing exclusively distal axons 4 ) were harvested, and equal amounts of protein were analysed by western blot. Western blotting using a CREB-family antibody that also recognises CREM and ATF1 indicated that only CREB is present in distal axons, and is dependent on the presence of NGF in the axon compartment ( Fig. 3a and see Supplementary Information, Fig. S1i ), although all three proteins were detected in the cell body-proximal axon fraction (Fig. 3a) .
The axonal localization of CREB was also examined using immunofluorescence microscopy. Axons were severed from cultured DRG explants to exclude potential contributions from anterograde transport of cell body-derived CREB. Immunofluorescence microscopy with a CREBspecific antibody revealed that axonal CREB protein was present when the media contained NGF, but not when the media was exchanged with NGF-free media for 3 h (Fig. 3b,c) , consistent with the western blot data. Although the majority of CREB protein localized to the nucleus, with substantially lower levels in axons (Fig. 3d) , the immunofluorescence microscopy signal in axons was specific, as similar immunofluorescence staining was observed using a different CREB-specific antibody that recognises a nonoverlapping epitope, and immunofluorescence staining was substantially reduced in DRG neurons transfected with CREBspecific siRNA, and in DRG neurons prepared from mouse embryos homozygous for a hypomorphic CREB allele 19 (see Supplementary Information, Fig. S1j-o) . The presence of CREB in severed axons was dependent on NGF and local translation, as replacement of the media with NGF-free media or NGF-replete media containing cycloheximide resulted in a loss of CREB immunoreactivity (Fig. 3b, c) . These data indicate that CREB is found in axons and its levels are dependent on NGF.
CREB mRNA is selectively translated in response to NGF NGF-dependent axonal CREB translation was then examined using a GFP-based reporter assay 22 . This reporter expresses a transcript encoding a destabilized enhanced GFP with a cellular half-life of 1 h (dEGFP), which enables dynamic changes in translational activity to be reflected by changes in fluorescence intensity 22 . The dEGFP construct also contains a myristoylation sequence, resulting in reduced diffusion of the reporter in the membrane 4, 22 . As a result of these two features, fluorescence signals reflect newly synthesised protein near the site of translation, as evident from their proximity to ribosomes 4 . Expressing the RhoA reporter myr-dEGFP 3´RhoA led to fluorescent puncta throughout axons that were only slightly affected by removal of NGF (see Supplementary Information, Fig. S2b ). These observations indicate that the CREB reporter is responsive to NGF but not to Sema3A, suggesting that the CREB 3´UTR contains a NGF-response element and that axons contain distinct signalling pathways that regulate the translation of different mRNA transcripts. The punctuate myr-dEGFP signals may reflect 'hotspots' of protein translation 22 , as these puncta colocalized with ribosomal protein S6, phospho-eIF4E and Staufen, but not mitochondria ( Fig. 4c and see Supplementary Information, Fig. S2c, d ).
Locally synthesized CREB is retrogradely trafficked to the nucleus
The importin proteins, which bind nuclear-localization sequences (NLSs) 24 , are present in axons and mediate the retrograde trafficking of axonally injected fluorescently labelled NLS peptides 25 . As CREB contains an NLS that mediates its nuclear localization 26 , axonal CREB may be retrogradely transported to the cell body. To determine whether endogenously expressed CREB is retrogradely trafficked, the time course of CREB reduction in axons when media was replaced with NGF-free media was examined. CREB levels decreased to baseline within 3 h of NGF removal, and returned to original levels 2 h after restoration of NGF, although significant recovery in CREB levels (~40%) was observed within 30 min of NGF restoration (Fig. 5a ). These treatments did not affect levels of the axonal protein GAP-43 (Fig. 5a ) or axonal CREB mRNA levels (see Supplementary Information, Fig. S2e ). The NGF-dependent restoration of CREB levels was abolished by ribosomal inhibitors (Fig. 5a ). The reduction of CREB levels on removal of NGF was unaffected by the presence of the proteasome inhibitor LLnL (Fig. 5b and see Supplementary Information, Fig. S2f ), indicating a proteasome-independent pathway for CREB removal from axons.
Application of colchicine, which prevents microtubule-dependent transport, abolished the reduction in CREB levels following removal of NGF (Fig. 5b) , indicating a microtubule-dependent process for the loss of CREB protein from axons. The possibility of retrograde transport is supported by the finding that the loss of CREB protein occurs first in distal axons, and then subsequently in medial and proximal axon segments (see Supplementary Information, Fig. S2g) .
To further examine retrograde trafficking of CREB, Dendra, a monomeric GFP relative that converts from green to red fluorescence on irradiation with blue or ultraviolet light 27 , was used. DRG explant cultures were infected with Sindbis virus encoding either Dendra or Dendra-CREB transcripts that contained a minimal 3´UTR axon-targeting element 28, 29 . Dendra and Dendra-CREB were photoconverted in selected growth cones (Fig. 6a) . The rate of Dendra movement towards the cell body matched the rate predicted by passive diffusion (Fig. 6b) . In contrast, photoconverted Dendra-CREB was observed to move at a substantially higher, and constant, rate towards the cell body of 7.8-8.8 mm h -1 (Fig. 6a, b) , similarly to previously measured rates of retrograde trafficking 30, 31 . Retrograde transport was significantly blocked by colchicine or ethacrynic acid (a dynein inhibitor 32 ), suggesting microtubule motor-dependent active transport of Dendra-CREB from the axon (Fig. 6b) . Photoconversion of a 40-µm section of axon approximately 1000 µm from the cell body was associated with accumulation of photoconverted Dendra-CREB, but not Dendra, in the nucleus within 20 min (Fig. 6c, d) .
Signalling endosomes containing TrkA, the NGF receptor, are trafficked from distal axons to the cell body 7 and mediate the activation of Erk5, which is required for CREB phosphorylation in response to axonally applied NGF 33 . Punctate regions of phospho-TrkA (pTrkA) immunoreactivity were observed along the length of axons of DRG neurons cultured in the presence of NGF (see Supplementary Information,  Fig. S2h ), in a distribution pattern consistent with previous reports of TrkA-signalling endosomes in axons 34 . These regions of pTrkA reactivity also contain phosphorylated Erk5 (see Supplementary Information,  Fig. S2h ). Interestingly, axonal CREB protein colocalized with these sites of pTrkA immunoreactivity along axons (see Supplementary  Information, Fig. S2h ), indicating that axonal CREB may be in proximity to TrkA-signalling complexes in axons.
Axonal CREB is required for the accumulation of pCREB in the nucleus induced by application of NGF to axons
We next asked whether the amounts of CREB synthesized in axons make a substantial contribution to nuclear levels of CREB. Axonal CREB mRNA was knocked down by compartmentalized siRNA transfection 35 , while BOC-Asp(OMe) -FMK (BAF; a caspase inhibitor) was included in the cell body compartment to prevent neuronal death 36 . Transfection of CREB-specific siRNA into the axon compartment of dissociated DRG neurons in compartmented chambers resulted in axonal knockdown of CREB protein (72.8 ± 5.2%) and CREB mRNA (82.5 ± 4.3%), but did not lead to a reduction in CREB mRNA or protein levels in the cell body compartment (Fig. 7a, b and see Supplementary Information, Fig. S3a, b) . Similarly, reductions in CREB protein levels, as observed by western blotting, are seen selectively in axons (see Supplementary Information, Fig. S3c ). These effects are specific, as β-actin mRNA levels in axons or cell bodies were not affected by axonal transfection of CREB-specific siRNA (see Supplementary Information, Fig. S3b ). Unlike CREB, which is readily detected in the nucleus, Ser 133-phosphorylated CREB (pCREB) is present at negligible levels in the nuclei of unstimulated sensory neurons 37, 38 . The low basal level of pCREB makes neurons highly responsive to increases in pCREB levels, which occurs on application of neurotrophin to axons 38 ( Fig. 7c and see Supplementary Information, Fig. S3d) . Treatment of axons with NGF resulted in increased levels of pCREB in the nucleus within 20 min, which was unaffected by axonal transfection of a control siRNA. Axonal transfection of CREB-specific siRNA significantly reduced the ability of axonally applied NGF to induce this rapid increase in nuclear pCREB levels ( Fig. 7c and see Supplementary Information, Fig. S3d ), but did not have a significant effect on cell body accumulation of pTrkA or pERK5 (see Supplementary Information, Fig. S3e, f ) , suggesting that this effect is not due to inhibition of retrograde transport of signalling endosomes. Knockdown of axonal CREB mRNA also did not affect nuclear pCREB accumulation induced by stimulation of cell bodies with NGF (Fig. 7c) , demonstrating that axon-specific CREB knockdown does not have a general inhibitory effect on NGF signalling or CREB phosphorylation. The appearance of pCREB in the nucleus within 20 min of NGF treatment is consistent with the time required for CREB to be transported across the 1-mm divider, based on the trafficking rates measured for Dendra-CREB (Fig. 6b) . Thus, although axonal synthesis does not contribute substantially to the total amount of nuclear CREB, these data indicate that the axonally synthesised pool of CREB accounts for the majority of the pCREB that appears in the nucleus when distal axons are stimulated with NGF. Axonal CREB mediates the induction of CRE-dependent transcription We wanted to determine whether axon-derived CREB is capable of affecting CRE-dependent transcription. Axons of dissociated DRG neurons in compartmented chambers were subjected to either NGF-replete or NGF-free media and siRNA at DIV 5. BAF was included in the cell body compartment to prevent neuronal death. At DIV 6, cell bodies were infected with adenovirus encoding a CRE-luciferase reporter, and cellular luciferase levels were measured 24 h later. Bath application of NGF to DRG neurons lead to a dose-dependent increase in luciferase immunofluorescence, but did not affect a control protein (see Supplementary  Information, Fig. S3g ). Axonal application of NGF increased luciferase levels, which was prevented by axon-specific transfection of CREBspecific siRNA, but not control siRNA (Fig. 7d) . Knockdown of axonal CREB mRNA did not affect luciferase transcription induced by NGF applied to the cell bodies (Fig. 7d) , indicating that axonal CREB knockdown does not inhibit the reporter non-specifically. Thus, axon-derived CREB is necessary for CRE-dependent transcription induced by application of NGF to distal axons.
Axonal CREB is required for NGF-induced retrograde survival
A role for CREB in DRG neuron survival is demonstrated by the loss of ~75% of these neurons in CREB-null mice 13 . To determine the role of the axonal CREB in neuronal survival, DRG neurons were cultured in compartmented chambers and axons were transfected with either control or CREB-specific siRNA. Neuronal survival induced by axonal application of NGF was unaffected by control siRNA, but was markedly impaired by transfection with either of two CREB-specific siRNAs (Fig. 7e) . Axonspecific transfection of CREB-specific siRNA did not affect cell survival elicited by application of NGF to cell bodies (Fig. 7e) , indicating that NGF signalling at cell bodies does not require axonal CREB. The impairment in survival observed after knockdown of axonal CREB mRNA was comparable to that observed when CREB mRNA was knocked down throughout both cell bodies and axons by transfection of cell bodies with CREB-specific siRNA (Fig. 7e) , and similar to the levels of survival observed when both cell bodies and axons are deprived of NGF (Fig. 1e and see Supplementary  Information, Fig. S1d ) 33 . These data indicate that axonal CREB translation is required for survival elicited by NGF signalling in distal axons.
DISCUSSION
Our studies reveal a role for intra-axonal mRNA translation in mediating communication between distal axons and the nucleus. CREB mRNA is localized to the axons of DRG neurons and is translated in response to NGF signalling. Axon-derived CREB is the source of the pCREB that is observed in the nucleus following exposure of distal axons to NGF, and is required for the increase in CRE-dependent transcription observed when distal axons are stimulated with NGF. Furthermore, neuronal survival elicited by NGF signalling at distal axons requires axon-derived CREB. These data indicate that the retrograde signal generated on axonal application of NGF includes axonally synthesised CREB (Fig. 8) . Our findings identify a novel function for local translation involving the translation and retrograde trafficking of transcription factors from the axon to the neuronal nucleus. The regulation of local protein synthesis within axons adds to the previously described signalling pathways downstream of NGF and TrkA. NGF signalling is selective as it leads to the induction of the CREB mRNA translational reporter, but not the RhoA reporter, which is regulated by Sema3A 4 . This selectivity suggests the presence of sequence elements in the CREB 3´UTR that specifically confer NGF responsiveness.
A common feature of many types of growth factor signalling pathways, including NGF signalling, is the occurrence of intracellular 'signalling platforms' that function as localized signal transduction units 39 . NGF-mediated TrkA signalling can occur through TrkA at the plasma membrane, as well as TrkA localized to endosomes that form on internalization of NGF-TrkA complexes 40, 41 . These distinct platforms are characterized by unique cohorts of proximally localized TrkA effectors 40, 41 . Retrograde trafficking of TrkA-signalling endosomes, containing both catalytically active TrkA and specific TrkA effectors, is associated with an increase in pCREB levels in the nucleus in a Mek5 and Erk5-dependent pathway 33 . However, whether CREB is similarly compartmentalized into an effector pool that is preferentially regulated by the signalling endosome has not previously been addressed. We observe that CREB colocalizes with pTrkA in axons and as both CREB and TrkA-signalling endosomes are retrogradely trafficked, the proximity of the pool of axonally derived CREB may make it preferentially accessible to phosphorylation by TrkA effectors. such as Erk5 (ref. 33) . As TrkA kinase activity in the cell body is required for CREB phosphorylation 37 , several models could explain how CREB phosphorylation is regulated: first, CREB is not phosphorylated until it arrives in the cell body; second, CREB is readily dephosphorylated and TrkA activity is required to maintain CREB in a phosphorylated state when it arrives in the cell body; or third, TrkA activity is required to inactivate a cell body phosphatase.
Transcriptional effects elicited by axonal signalling require that an axon-derived signal be conveyed to the cell body. An inherent requirement in this type of signalling is that the axon-derived signal must somehow be distinguished from what would presumably be a much larger amount of similar molecules in the cell body. The low basal level of pCREB in the nucleus of unstimulated neurons 33 may allow small increases in the amount of pCREB derived from the axon to result in a substantial elevation in pCREB-dependent transcriptional activity. Our results indicate that axonally synthesized CREB is capable of exerting transcriptional effects in the nucleus by functioning as the source of the pCREB that appears in the nucleus after axonal application of NGF. Because the transcriptional effects of CREB are affected by its phosphorylation at sites other than Ser 133 (refs 42, 43) , as well as by protein-protein interactions 43 , axon-specific CREB modifications may also impart axonally synthesized CREB with unique transcriptional effects that differ from cell body-localized CREB.
Several examples of transcription factors or transcriptional regulators localized to dendrites, and less frequently, developing axons, have been described; these include CREB 21 and NF-κB 44 in dendrites, and Nervy in axons 45 . These transcription factors may have non-nuclear functions; for example, in axons, Nervy acts as an adapter protein for signalling from Plexin receptors 45 . In the case of dendritic NF-κB, a role in transcriptional regulation has been proposed 44 ; however, these studies have not been able to differentiate between the role of the somatic and dendritic pool of NF-κB. Similarly, although it is clear that CREB can be synthesized in dendrites 21 , the inherent difficulties in selectively abolishing the dendritic CREB pool have prevented a thorough elucidation of the exact role of dendritically synthesised CREB in neuronal signalling. By selectively abolishing axonal CREB mRNA, the data presented here supports a nuclear role for extrasomatic pools of CREB.
During development, axons encounter a variety of signals that affect multiple aspects of neuronal development (such as axonal elongation, branching and pathfinding), as well as synaptogenesis and neuronal differentiation 9, 46, 47 . Increasing evidence suggests that many of these processes involve retrograde signals that affect gene transcription. Translation and retrograde trafficking of axonally localized transcription factor mRNAs in response to target-derived signalling molecules could, therefore, constitute a general mechanism by which signalling at growth cones can selectively and temporally regulate gene transcription during neuronal development.
METHODS
Primary cell culture. E15 rat or E13 mouse embryonic DR) explants were plated on glass-bottom culture dishes (MatTek) or glass coverslips pre-coated with 33 µg ml -1 poly-d-lysine and 1 µg ml -1 laminin. CREB α/β-/+ animals used to generate CREB α/β-/-embryos were from Jackson Labs. E15-dissociated DRG neurons were prepared as previously described 4 . DRGs were cultured in B27/Neurobasal medium (Invitrogen) supplemented with 100 ng ml -1 NGF and 20 µM 5´-fluorodeoxyuridine (5-FdU) for 3 days. siRNA-mediated knockdown in DRG neurons has been described previously 48 and was performed using siRNAs listed in the Supplementary Information, Table S1 . For measurements of CREB levels in isolated axons, axons were severed from cell bodies by removing the explant with a flame-sharpened Pasteur pipette 4 . Modified Boyden chambers were based on the procedure of Twiss 17 , and modified to obtain distal axons, as previously described 4 . mRNA from harvested axons 4 was used to prepare a cDNA library using a modified, unbiased single-cell protocol 18 , as described in the Supplementary Information, Methods. Compartmented (Campenot) cultures were prepared as previously described 12 (see Supplementary Information, Methods) .
In situ hybridization. Sense oligonucleotides (see Supplementary Information, Table S1 ) were synthesised with a T7 promoter site at their 3´ end. Antisense riboprobes were in vitro transcribed from the sense oligonucleotides using the MEGAscript T7 transcription kit (Ambion) with digoxigenin-conjugated UTP. DRGs (DIV 3) were fixed overnight at 4 °C in 4% paraformaldehyde in cytoskeleton buffer (CSB: 10 mM MES at pH 6.1, 138 mM KCl, 3 mM MgCl 2 , 2 mM EGTA and 0.4 M sucrose). Washes were performed in TBST (20 mM Tris at pH 8.0, 150 mM NaCl and 0.1% Triton X-100) for 3 × 5 min. DRGs were permeabilized in 0.5% Triton X-100 in TBS for 10 min and post-fixed in 4% PFA in TBS for 5 min, followed by fresh acetylation buffer (0.25% acetic anhydride, 0.1 M HEPES) for 10 min, and equilibration with 4× SSC in 50% formamide for 30 min. Cultures were incubated with 15 ng riboprobes (see Supplementary Information, Table S1 ) in 15 µl hybridization buffer (10% dextran sulfate, 4× SSC, 1× Denhardt's solution, 40% formamide, 20 mM ribonucleoside vanadyl complex, 10 mM DTT, 1 mg ml -1 yeast tRNA and 1 mg ml -1 salmon sperm DNA) at 37 °C overnight. The coverslips were washed with 40% formamide in 1× SSC at 37 °C for 20 min, and three times each with 1× SSC and 0.1× SSC at room temperature for 5 min. Neurons were blocked with blocking buffer (100 mM Tris-HCl at pH 8.0, 150 mM NaCl, 8% formamide, 5% BSA, 2.5% normal horse serum and 2.5% normal goat serum) for 30 min. Hybridization was detected with anti-digoxin antibody (see Supplementary Information, Table S4 ), which was precleared with rat embryo power in blocking buffer for 2 h at 25 °C. Mean fluorescence intensity elicited by the scrambled probe was subsequently deducted from all FISH data to produce specific labelling intensity for each probe.
Quantification of CREB protein levels. Images and measurements of signals in axons were taken from the terminal 50 µm of the axon, except where indicated. Analysed axons were a minimum of 2000 µm for all experiments. DRGs were fixed with 4% PFA in CBS overnight at 4 °C, permeabilized with 0.5% Triton X-100 in TBS, and blocked in 4% BSA in TBS for 1 h. DRGs were labelled with antibodies (see Supplementary Information, Table S4 ) in 2% BSA in 0.1% Triton X-100 in TBS overnight at 4 °C. For image acquisition details, see Supplementary Information, Methods.
Generation and infection of recombinant viruses.
A modified Sindbis vector, pSinRep5, which contains a point mutation in nsP2 (P726S) that reduces cytotoxicity in neurons 23 was used, and the helper plasmid DH-BB (gift from S. Schlesinger, Washington University, St. Louis), as previously described 4 . Reporter experiments utilized the myr-dEGFP system 22 , except that a d1EGFP variant (that is, an EGFP with a 1 h half-life) was used, also as described previously 4 . pSinRep5-myr-dEGFP 3´CREB and pSinRep5-myr-dEGFP 3´RhoA , contained the full-length 3´UTR of the human CREB mRNA or the 3´UTR of human RhoA mRNA, fused to the viral 3´CSE (conserved sequence element). For Sindbis virus encoding Dendra constructs, the virus contained the open reading frame (ORF) of Dendra and, in the case of pSinRep5-Dendra-CREB, the full ORF of human CREB, followed by a 54 nucleotide minimal axonal targeting element 28 . In the case of IRES-driven Sindbis virus, the pSinRep constructs contained a human encephalomyocarditis viral IRES element from vector pIRES-hyg (BD Biosciences). Sindbis pseudoviruses were prepared according to the manufacturer's instructions (Invitrogen), purified on a sucrose gradient, concentrated on YM-100 micron columns, resuspended in Neurobasal medium, and titred using BHK-21 cells. A CRE-luciferase adenovirus reporter was generated by subcloning the complete CRE-Luc reporter gene from vector pCRE-Luc (BD Biosciences) into pAd/PL-DEST (Invitrogen). Virus production and amplification was performed in HEK293A cells, according to the manufacturer's instructions. Adenovirus was purified using the ViraKit AdenoMini-4 system (Virapur), and titred using HEK293T cells. DRGs were infected with equal infectious units of recombinant virus at DIV6 and luciferase levels were measured 24 h later. Data analysis and presentation. All statistical P values in this study were determined using ANOVA from experiments repeated a minimum of three times, unless stated otherwise. All data are presented as mean ± s.e.m. n values are represented on all graphs and defined in legends, unless stated otherwise (see Supplementary Information, Methods, for more details on data acquisition and handling). 4 . The reporter contains a myristoylated, destabilised EGFP (dEGFP) with the 3'UTR of RhoA or histone H1f0, expressed under control of the Sindbis subgenomic promoter (P SG ). (b) E15 DRG explant cultures were infected with Sindbis constructs expressing myrdEGFP 3'RhoA or myr-dEGFP 3'H1f0 on DIV3 and fluorescence images were collected after 24h. Explants infected with myr-dEGFP 3'RhoA and cultured in the presence of NGF exhibited fluorescent puncta distributed throughout axons (0 h). Following replacement of the media with NGF-free media for 2 h, puncta intensity was not significantly affected (2 h). Explants infected with myr-dEGFP 3'H1f0 and cultured in the presence of NGF did not exhibit fluorescent puncta in axons. Scale bar, 25 μm. (c) myr-dEGFP 3'CREB -infected axons were counter-stained by immunofluorescence using antibodies specific to translational marker p-eIF4E, RNP-associating protein Staufen, and mitochondrial marker VDAC/Porin1. myr-dEGFP was found in some, but not all ribosomal clusters (Fig. 4c) , suggesting that myr-dEGFP-negative clusters are either translationally inactive, that they translate CREB mRNA in response to different stimuli, or that their function involves the translation of other mRNAs. Scale bar, 10 μm. (d) Axons from DIV3 DRGs were analysed for CREB and mitochondrial localisations by immunofluorescence using CREBspecific and VDAC/porin1-specific antibodies. Scale bar, 10 μm. (e) Axons were severed from DIV3 DRG explant cultures, and incubated with 0 or 100 ng/ml NGF for 3 h. CREB mRNA was detected by FISH using a CREB specific riboprobe. CREB mRNA levels did not significantly change during the course of the experiments. Numbers on bars represent n axons per condition.. (f) 40 μM LLnL was added to myr-dEGFP 3'CREB -infected axons. Within 5 min, the eGFP fluorescence signal increased twofold, due to inhibition of proteasomedependent degradation of the destabilised EGFP. Scale bar, 10 μm. (g) 3DIV dissociated DRGs were treated with NGF-free and NGF-replete media as in Fig. 5 . CREB levels were assayed by immunofluorescence in contiguous axons: distal segments (450-500μm), medial segments (250-300μm) and proximal segments (50-100μm) from the same axon were determined by their distances from the cell body. n≥10 axons per data point. *p<0.01. (h) Axons of DIV3 DRG explant cultures were analysed by immunofluorescence for NGF effectors CREB, pTrkA and pErk5 at 3 DIV. Scale bar, 5μm. 
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